Lantern Pharma公布2025年第四季度及全年财务业绩并披露业务进展

美股速递
Mar 31

Lantern Pharma Inc.近日发布2025财年第四季度及全年财务报告,同步更新公司核心业务发展动态。通过人工智能驱动的新型药物开发模式,企业正加速推进多项肿瘤靶向疗法的临床研究。最新财报显示,其研发管线取得突破性进展,现金流管理策略持续优化,为长期价值创造奠定坚实基础。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10